Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Consolidated Net IncomeCost of RevenueDepreciation & Amortization - TotalEBITEBITDAEBTEPS (Weighted Average and Diluted)Gross ProfitIncome from Continuing OperationsIncome towards Parent CompanyInterest & Investment IncomeInterest ExpensesNet Income towards Common StockholdersNon Operating Investment IncomeOperating ExpensesOperating IncomeOther Operating ExpensesProfit After TaxResearch & DevelopmentRevenueSelling, General & AdministrativeTax ProvisionsTax Rate
Others
Ratios

MDxHealth (MDXH) EBIT: 2021-2025

Historic EBIT for MDxHealth (MDXH) over the last 5 years, with Sep 2025 value amounting to $26.4 million.

  • MDxHealth's EBIT rose 20.55% to $26.4 million in Q3 2025 from the same period last year, while for Sep 2025 it was $111.5 million, marking a year-over-year increase of 14.06%. This contributed to the annual value of -$24.7 million for FY2024, which is 9.53% up from last year.
  • MDxHealth's EBIT amounted to $26.4 million in Q3 2025, which was down 28.79% from $37.0 million recorded in Q2 2025.
  • In the past 5 years, MDxHealth's EBIT ranged from a high of $13.2 billion in Q2 2022 and a low of $13.5 million during Q1 2022.
  • In the last 3 years, MDxHealth's EBIT had a median value of $22.3 million in 2023 and averaged $23.7 million.
  • In the last 5 years, MDxHealth's EBIT crashed by 99.87% in 2023 and then skyrocketed by 95.41% in 2024.
  • MRQ analysis of 5 years shows MDxHealth's EBIT stood at $22.7 million in 2021, then tumbled by 39.23% to $13.8 million in 2022, then soared by 61.61% to $22.3 million in 2023, then increased by 12.79% to $25.1 million in 2024, then rose by 5.12% to $26.4 million in 2025.
  • Its last three reported values are $26.4 million in Q3 2025, $37.0 million for Q2 2025, and $22.9 million during Q1 2025.